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The Ganges delta has been well known for its high
endemicity for cholera for a long time. Several
pandemics of cholera originated from this region.1
A year-long hospital-based surveillance for cholera
was undertaken in two major government hospitals
in Howrah, the twin city to Kolkata (capital of West
Bengal, India), situated on the banks of the river
Ganges. Bi-weekly stool samples were collected
from all diarrhoea cases admitted to these two
hospitals and were screened for Vibrio cholerae
using a standard microbiological technique.2 The
antibiotic susceptibility of the isolates was tested
by the Kirby-Bauer disc diffusion technique using
commercially available discs.3
A total of 1909 diarrhoea stool samples were
collected of which 296 (15.5%) were positive for
Vibrio cholerae. Figure 1 shows that although cases
were observed during all months of the year, there
was a distinct seasonality of the diarrhoea cases and
cholera, showing a marked increase during the
months of July and August, which is the monsoon
season in this part of West Bengal state. There was a
low ebb in winter. Figure 2 displays the isolation of
vibrios by age group with reference to the number of
diarrhoea cases screened, and indicates that cho-
lera affected all age groups. In fact, 13.7% of the
diarrhoea-affected children below two years of
age suffered from cholera, emphasizing the high
endemicity of the disease as well as improper feed-
ing practices including the breast feeding of these
children.4
Antimicrobial susceptibility testing revealed that
all the V. cholerae O1 strains were uniformly resis-
tant to co-trimoxazole, furazolidone and nalidixic
acid. A few strains were also found to be resistant to
ciprofloxacin and norfloxacin. By contrast, V. cho-
lerae O139 strains were uniformly resistant to nali-
dixic acid, norfloxacin and ciprofloxacin. However,
both O1 and O139 strains were sensitive to tetra-1201-9712/$30.00 # 2005 International Society for Infectious Diseas
doi:10.1016/j.ijid.2004.06.008cycline. Appearance of resistance to norfloxacin and
ciprofloxacin raises serious concerns since these two
drugs are widely used for the treatment of cholera.
Furazolidone, which is recommended for the treat-
ment of cholera in children and pregnant women,
has become ineffective. Fortunately the strains are
still highly sensitive to tetracycline, but this drug is
not recommended for use in children for fear of its
accumulation in the teeth and growing ends of the
bones.
An ongoing hospital-based surveillance con-
ducted since 1995 by our institute at the Infectious
Diseases Hospital in Kolkata shows similar trends of
antimicrobial susceptibility pattern and cholera
incidence, with marked increase during the mon-
soon season.5
Conventional preventive intervention measures
for cholera control include the provision of safe
drinking water, proper disposal of excreta, improve-
ment of environmental sanitation and personal
hygiene including good hand washing practices.6
However, the implementation of most of these
recommendations is not immediately possible due
to resource constraints. Therefore vaccination
against cholera remains an attractive additional
public health tool.
WC/rBS and CVD-103-HgR are the two cholera
vaccines currently recommended by WHO for tra-
velers from developed countries to developing
countries.7 Since areas such as Howrah district
are highly endemic for cholera and have a distinct
seasonality, it may be justified to recommend
vaccination against cholera just before the cholera
season with the objective not only to prevent
cholera cases but also to avoid outbreaks, hospita-
lization, deaths and overall loss of DALYs (disability
adjusted life years). However, the cost-effective-
ness of such a major public health intervention
should be carefully examined in light of the govern-
ment’s annual health budget and compared to
the anticipated returns as well as the social and
economic implications. This recommendation is
generally applicable to all areas endemic for cholera.es. Published by Elsevier Ltd. All rights reserved.
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Figure 1 Monthwise isolation of V. cholerae.
Figure 2 Isolation of V. cholerae by age group.
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